Ginsenoside Rg3 promotes beta-amyloid peptide degradation by enhancing gene expression of neprilysin

Journal of Pharmacy and Pharmacology

Volumn 61, Issue 3, 2009, Pages 375-380

  Lingling, Yang ^a   Jianrong, Hao ^a   Jing, Zhang ^a   Wenjun, Xia ^a   Xifeng, Dong ^b   Xiaoyan, Hu ^a   Feng, Kong ^a   Xing, Cui ^a  

^a SHANDONG UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Beta amyloid peptide; Ginsenoside; Neprilysin; Swedish mutant amyloid precursor protein

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; GINSENOSIDE RG 3; MEMBRANE METALLOENDOPEPTIDASE; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); GINSENOSIDE; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GINSENG; HUMAN; HUMAN CELL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; CHEMISTRY; CHINESE MEDICINE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; NEUROBLASTOMA; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BLOTTING, WESTERN; CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GINSENOSIDES; HUMANS; MEDICINE, CHINESE TRADITIONAL; NEPRILYSIN; NEUROBLASTOMA; PANAX; PEPTIDE FRAGMENTS; POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 64549158006     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp/61.03.0013     Document Type: Article

References (37)

1. Selkoe DJ. Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J Alzheimers Dis 2001; 3: 75-80.
2. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 297: 353-356.
3. Forman MS et al. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med 2004; 10: 1055-1063.
4. Seubert P et al. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature 1992; 359: 325-327.
5. Howell S et al. Neutral endopeptidase can hydrolyze beta-amyloid( 1-40) but shows no effect on beta-amyloid precursor protein metabolism. Peptides 1995; 16: 647-652.
6. Eckman EA et al. Degradation of the Alzheimer's amyloid β peptide by endothelin-converting enzyme. J Biol Chem 2001; 276: 24540-24548.
7. Eckman EA et al. Alzheimer's disease beta-amyloid peptide is increased in mice deficient in endothelin-converting enzyme. J Biol Chem 2003; 278: 2081-2084.
8. Kurochkin IV, Goto S. Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett 1994; 345: 33-37.
9. McDermott JR, Gibson AM. Degradation of Alzheimer's beta-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme. Neurochem Res 1997; 22: 49-56.
10. Qiu WQ et al. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem 1998; 273: 32730-32738.
11. Chesneau V et al. Purified recombinant insulin-degrading enzyme degrades amyloid β-protein but does not promote its oligomerization. Biochem J 2000; 509-516.
12. Vekrellis K et al. Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme. J Neurosci 2000; 20: 1657-1665.
13. Hu J et al. Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity. J Biol Chem 2001; 276: 47863-47868.
14. Hama E et al. Clearance of extracellular and cell-associated amyloid beta peptide through viral expression of neprilysin in primary neurons. J Biochem 2001; 130: 721-726.
15. Iwata N et al. Metabolic regulation of brain Aβ by neprilysin. Science 2001; 292: 1550-1552.
16. Iwata N et al. Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-β peptide in mouse brain. J Neurosci 2004; 24: 991-998.
17. Marr RA et al. Neprilysin regulates amyloid Beta peptide levels. J Mol Neurosci 2004; 22: 5-11.
18. Attele AS et al. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 1999; 58: 1685-1693.
19. Liu ZQ et al. In vitro study of the relationship between the structure of ginsenoside and its antioxidative or prooxidative activity in free radical induced hemolysis of human erythrocytes. J Agric Food Chem 2003; 51: 2555-2558.
20. Yue PY et al. The angiosuppressive effects of 20(R)-ginsenoside Rg3. Biochem Pharmacol 2006; 72: 437-445.
21. Xu TM et al. Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer. Chin Med J (Engl) 2007; 120: 584-588.
22. Luo X et al. Characterization of gene expression regulated by American ginseng and ginsenoside Rg3 in human colorectal cancer cells. Int J Oncol 2008; 32: 975-983.
23. Chen F et al. Reductions in levels of the Alzheimer's amyloid beta peptide after oral administration of ginsenosides. FASEB J 2006; 20: 1269-1271.
24. Bormann H, Melzig MF. Inhibition of metallopeptidases by flavonoids and related compounds. Pharmazie 2000; 55: 129-132.
25. Axelman K et al. A clinical and genealogical investigation of a large Swedish Alzheimer family with a codon 670/671 amyloid precursor protein mutation. Arch Neurol 1994; 51: 1193-1197.
26. Tohda C et al. A beta(25-35)-induced memory impairment, axonal atrophy, and synaptic loss are ameliorated by M1, a metabolite of protopanaxadiol-type saponins. Neuropsychopharmacology 2004; 29: 860-868.
27. Lian XY et al. Protective effects of ginseng components in a rodent model of neurodegeneration. Ann Neurol 2005; 57: 642-648.
28. Koo BS et al. Attenuating effect of a traditional korean formulation, Paeng-Jo-Yeon-Nyeon-Baek-Ja-In-Hwan (PJBH), on hydrogen peroxide-induced injury in PC12 cells. Phytother Res 2004; 18: 488-493.
29. Kim YC et al. Ginsenosides Rb1 and Rg3 protect cultured rat cortical cells from glutamate-induced neurodegeneration. J Neurosci Res 1998; 53: 426-432.
30. Tohda C et al. Search for natural products related to regeneration of the neuronal network. Neurosignals 2005; 14: 34-45.
31. Bao HY et al. Memory enhancing and neuroprotective effects of selected ginsenosides. Arch Pharm Res 2005; 28: 335-342.
32. Nishijo H et al. Proof of the mysterious efficacy of ginseng: basic and clinical trials: effects of red ginseng on learning and memory deficits in an animal model of amnesia. J Pharmacol Sci 2004; 95: 145-152.
33. Petkov VD et al. Behavioral effects of Ginkgo biloba L., Panax ginseng C.A. Mey. and Gincosan. Am J Chin Med 2003; 31: 841-855.
34. Wang TL et al. Attenuation of neutrophil and endothelial activation by intravenous morphine in patients with acute myocardial infarction. Am J Cardiol 1997; 80: 1532-1535.
35. Howell S et al. Membrane peptidases on human osteoblast-like cells in culture: hydrolysis of calcitonin and hormonal regulation of endopeptidase-24.11. Biochem J 1993; 290: 159-164.
36. Bae SJ et al. Substance P induced preprotachykinin-A mRNA, neutral endopeptidase mRNA and substance P in cultured normal fibroblasts. Int Arch Allergy Immunol 2002; 127: 316-321.
37. Joshi DD et al. Negative feedback on the effects of stem cell factor on hematopoiesis is partly mediated through neutral endopeptidase activity on substance P: a combined functional and proteomic study. Blood 2001; 98: 2697-2706.